Calcitriol - Rontag

Drug Profile

Calcitriol - Rontag

Alternative Names: Dihydroxycholecalciferol - Rontag; Dihydroxyvitamin D3 - Rontag; Rexamat

Latest Information Update: 19 Feb 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Rontag
  • Class Antipsoriatics; Chemoprotectants; Dihydroxycholecalciferols; Osteoporosis therapies; Small molecules; Vitamin D analogues
  • Mechanism of Action Vitamin D3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Hypoparathyroidism; Osteodystrophy

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 18 Feb 1999 Launched for Hypoparathyroidism in Argentina (PO)
  • 18 Feb 1999 Launched for Osteodystrophy in Argentina (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top